Doctor Michael Zile

Doctor Michael Zile

Medical University of South Carolina, Charleston (United States of America)

Dr. Zile is currently the Charles Ezra Daniel Professor of Medicine and Distinguished University Professor at the Medical University of South Carolina. He is a member of the Cardiology Division at the Ralph H. Johnson Department of Veteran's Affairs Health Care System in Charleston. He is the 2019 William S. Middleton Awardee for Outstanding Achievement in Biomedical Research and the 2020 South Carolina Governor’s Awardee for Excellence in Scientific Research. Dr. Zile's research career has focused on basic, translational and clinical research examining the mechanisms underlying the development and progression of heart failure; and determining how these mechanisms can be used to develop effective diagnostic, prognostic and treatment methods for Heart Failure, particularly heart failure with a preserved ejection fraction (HFpEF). Dr. Zile’s research has been funded for over 40 years by the NHLBI, VA, DOD, AHA, and industry and been summarized in more than 450 peer-reviewed publications.

Presentations Articles

BeAT-HF: long-term safety profile and outcomes

Event: ESC Congress 2023

Topic: Chronic Heart Failure

Session: Baroreflex activation therapy for HFrEF patients: long-term data and real-world experience

Access

Insights into the Effects of the COVID-19 Pandemic: Comprehensive Analysis from the GUIDE-HF Trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Treatment

Session: Late Breaking Trials - COVID-19

Access

Overview of neuromodulation devices in HFrEF.

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session: Neuromodulation for the management of patients with HFrEF: the present and the future

Access

Fibrosis is the bad guy

Event: Heart Failure 2018

Topic: Cardiac Biology and Physiology

Session: HFpEF – Still an unsolved enigma?

Access

Effect of sacubitril/valsartan on plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure and reduced ejection fraction.

Event: ESC Congress 2017

Topic: Heart failure, other

Session: Can we teach heart failure drugs new tricks?

Access

Doctor Michael Zile

Biography

Contributor content

BeAT-HF: long-term safety profile and outcomes

Insights into the Effects of the COVID-19 Pandemic: Comprehensive Analysis from the GUIDE-HF Trial

Overview of neuromodulation devices in HFrEF.

Fibrosis is the bad guy

Effect of sacubitril/valsartan on plasma biomarkers that reflect extracellular matrix regulatory mechanisms and collagen synthesis in patients with heart failure and reduced ejection fraction.

ESC 365 is supported by